113 related articles for article (PubMed ID: 25777472)
1. In this correspondence, preliminary data in 100 lithium users found that urine osmolality correlated with chronic kidney disease, diabetes mellitus, and hypothyroidism. We hypothesize that GSK-3β inhibition is a potential mechanism for lithium-associated medical illness.
Rej S; Segal M; Low NC; Mucsi I; Holcroft C; Shulman K; Looper KJ
Med Hypotheses; 2015 Jun; 84(6):602. PubMed ID: 25777472
[No Abstract] [Full Text] [Related]
2. Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria.
Rao R; Zhang MZ; Zhao M; Cai H; Harris RC; Breyer MD; Hao CM
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F642-9. PubMed ID: 15585669
[TBL] [Abstract][Full Text] [Related]
3. [Lithium and hypothyroidism].
Filion M; Hillel J
Union Med Can; 1985 Nov; 114(11):929-31, 933. PubMed ID: 4090097
[No Abstract] [Full Text] [Related]
4. Tissue injury after lithium treatment in human and rat postnatal kidney involves glycogen synthase kinase-3β-positive epithelium.
Kjaersgaard G; Madsen K; Marcussen N; Christensen S; Walter S; Jensen BL
Am J Physiol Renal Physiol; 2012 Feb; 302(4):F455-65. PubMed ID: 22088436
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
Gould TD; Manji HK
Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
[TBL] [Abstract][Full Text] [Related]
7. Lithium attenuates scopolamine-induced memory deficits with inhibition of GSK-3β and preservation of postsynaptic components.
Wu YY; Wang X; Tan L; Liu D; Liu XH; Wang Q; Wang JZ; Zhu LQ
J Alzheimers Dis; 2013; 37(3):515-27. PubMed ID: 23948897
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and correlates of renal disease in older lithium users: a population-based study.
Rej S; Shulman K; Herrmann N; Harel Z; Fischer HD; Fung K; Gruneir A
Am J Geriatr Psychiatry; 2014 Nov; 22(11):1075-82. PubMed ID: 24566239
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors.
Gould TD; Einat H; O'Donnell KC; Picchini AM; Schloesser RJ; Manji HK
Neuropsychopharmacology; 2007 Oct; 32(10):2173-83. PubMed ID: 17299510
[TBL] [Abstract][Full Text] [Related]
10. [Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].
Numajiri M; Aoki J; Iwahashi K; Fukamauchi F; Enomoto M; Yoshihara E; Murayama O; Nishizawa D; Ikeda K; Ishigooka J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Jun; 32(3):161-3. PubMed ID: 22834106
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment.
Pandey GN; Ren X; Rizavi HS; Dwivedi Y
J Psychiatr Res; 2010 Feb; 44(3):143-8. PubMed ID: 19717166
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.
Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P
J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders.
Rej S; Elie D; Mucsi I; Looper KJ; Segal M
Drugs Aging; 2015 Jan; 32(1):31-42. PubMed ID: 25519823
[TBL] [Abstract][Full Text] [Related]
14. GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression.
Beurel E; Kornprobst M; Blivet-Van Eggelpoël MJ; Ruiz-Ruiz C; Cadoret A; Capeau J; Desbois-Mouthon C
Exp Cell Res; 2004 Nov; 300(2):354-64. PubMed ID: 15475000
[TBL] [Abstract][Full Text] [Related]
15. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic lithium alleviates postoperative cognition impairment by phosphorylating hippocampal glycogen synthase kinase-3β (Ser9) in aged rats.
Zhao L; Wang F; Gui B; Hua F; Qian Y
Exp Gerontol; 2011 Dec; 46(12):1031-6. PubMed ID: 21945291
[TBL] [Abstract][Full Text] [Related]
17. Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders.
Serretti A; Benedetti F; Mandelli L; Calati R; Caneva B; Lorenzi C; Fontana V; Colombo C; Smeraldi E
Psychiatry Res; 2008 Mar; 158(2):132-40. PubMed ID: 17976739
[TBL] [Abstract][Full Text] [Related]
18. RBC choline and renal disorders during lithium treatment.
Gutterman DF; Correa EI; DePaulo JR; Coyle JT
Am J Psychiatry; 1985 Apr; 142(4):493-5. PubMed ID: 3976925
[TBL] [Abstract][Full Text] [Related]
19. Biphasic dose-dependent effect of lithium chloride on survival of human hormone-dependent breast cancer cells (MCF-7).
Suganthi M; Sangeetha G; Gayathri G; Ravi Sankar B
Biol Trace Elem Res; 2012 Dec; 150(1-3):477-86. PubMed ID: 23054864
[TBL] [Abstract][Full Text] [Related]
20. Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice.
Xia Y; Rao J; Yao A; Zhang F; Li G; Wang X; Lu L
Eur J Pharmacol; 2012 Dec; 697(1-3):117-25. PubMed ID: 23051669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
